Respiratory Monitoring Device Market Size

Respiratory Monitoring Device Market Insights

Global Respiratory Monitoring Device Market size was valued at USD 4.6 billion in 2023 and is poised to grow from USD 4.92 billion in 2024 to USD 8.39 billion by 2032, growing at a CAGR of 6.9% during the forecast period (2025-2032).

During the COVID-19 pandemic, the worldwide market for respiratory monitoring devices has experienced exponential growth. Patients who have COVID-19 may experience severe respiratory problems. As a result, there is now a greater use of respiratory monitoring equipment in home care and medical settings. Over the course of the forecast period, rising health care spending by governments in developing nations like India and an increase in the prevalence of respiratory illnesses are expected to boost the global market. In the upcoming years, it is anticipated that product innovations and technical developments will propel the global market for respiratory monitoring devices. All things considered, respiratory monitoring equipment will remain crucial due to the rise in respiratory illnesses and the fluctuations in pollution levels.

Over the past ten years, people's life expectancies have increased. The population pool in all the age groups has increased because of this. An individual's immune system deteriorates with age. Therefore, the increased number of elderly people raises their risk of developing illnesses. Compared to 71% in rich nations, the number of elderly persons in less developed nations is expected to increase by more than 250% between 2010 and 2050. The likelihood of developing respiratory illnesses rises with age. Over the forecast period, this is expected to increase demand for therapeutic respiratory equipment. In the United States, sleep apnea prevalence is comparable to that of diabetes and asthma. The need for respiratory monitoring equipment is being driven by this.

FAQs

Important Players Put Partnerships First to Get an Edge Over Their Rivals. To keep ahead of the competition, major competitors in the market are collaborating with other businesses. To broaden their product offering, numerous businesses are also investing in the introduction of new products. Players also employ mergers and acquisitions as important tactics to diversify their product offerings. 'Medtronic plc (Ireland) ', 'GE Healthcare (United States) ', 'Philips Healthcare (Netherlands) ', 'ResMed Inc. (United States) ', 'Masimo Corporation (United States) ', 'Nihon Kohden Corporation (Japan) ', 'Siemens Healthineers (Germany) ', 'MGC Diagnostics Corporation (United States) ', 'Hamilton Medical AG (Switzerland) ', 'Getinge AB (Sweden) ', 'Baxter International Inc. (United States) ', 'Teleflex Incorporated (United States) ', 'Invacare Corporation (United States) ', 'Fisher & Paykel Healthcare Corporation Limited (New Zealand) ', '3M Company (United States)'

The need for monitoring equipment has surged because of growing public and professional awareness of the significance of respiratory health. Better results and an enhanced quality of life can result from early detection and monitoring of respiratory diseases. The adoption of remote patient monitoring, the heightened focus on respiratory health, and the spike in demand for products like pulse oximeters during the pandemic have all contributed to the market's rise.

Rise of Portable and Home-Based Devices: The market for respiratory care devices is seeing notable developments that are indicative of the rising need for cutting-edge technologies in the diagnosis, treatment, and management of respiratory diseases. The growing use of portable and home-based respiratory care equipment is one noteworthy trend. People who suffer from long-term respiratory conditions, such as asthma and chronic obstructive pulmonary disease (COPD), are finding that home ventilators and portable oxygen concentrators are convenient and easily accessible options. This pattern reduces the need for frequent hospital visits by enabling people to maintain their respiratory health from the comfort of their homes, which is consistent with the larger movement towards patient-centric care.

The global market for respiratory monitoring devices is dominated by North America and Europe for several reasons. These areas are known for their sophisticated technology uptake, well-established healthcare infrastructure, and high healthcare costs. Furthermore, these areas have a comparatively high prevalence of respiratory conditions including asthma and COPD, which fuels the need for respiratory monitoring equipment. Furthermore, North America and Europe dominate this market due to favorable government initiatives, significant R&D, and the presence of major market players. As a result, these regions are important for respiratory monitoring technology innovation and revenue generation.